184 related articles for article (PubMed ID: 25371577)
1. Antifungal and antihepatotoxic effects of sepia ink extract against oxidative stress as a risk factor of invasive pulmonary aspergillosis in neutropenic mice.
Fahmy SR; Soliman AM; Ali EM
Afr J Tradit Complement Altern Med; 2014; 11(3):148-59. PubMed ID: 25371577
[TBL] [Abstract][Full Text] [Related]
2. NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model.
Xu P; Qu JM; Xu JF; Zhang J; Jiang HN; Zhang HJ
Acta Pharmacol Sin; 2009 Jul; 30(7):980-6. PubMed ID: 19575001
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice.
Feng C; Zhang M; Zhang S; Zhang J; Li C; Zhou J
BMC Pulm Med; 2021 Jan; 21(1):31. PubMed ID: 33468116
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis.
Lewis RE; Albert ND; Kontoyiannis DP
Antimicrob Agents Chemother; 2008 Nov; 52(11):4178-80. PubMed ID: 18725439
[TBL] [Abstract][Full Text] [Related]
5. Application of a low molecular weight antifungal protein from Penicillium chrysogenum (PAF) to treat pulmonary aspergillosis in mice.
Palicz Z; Gáll T; Leiter É; Kollár S; Kovács I; Miszti-Blasius K; Pócsi I; Csernoch L; Szentesi P
Emerg Microbes Infect; 2016 Nov; 5(11):e114. PubMed ID: 27826143
[TBL] [Abstract][Full Text] [Related]
6. Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis.
Ambati S; Ellis EC; Pham T; Lewis ZA; Lin X; Meagher RB
mBio; 2021 Feb; 12(1):. PubMed ID: 33622715
[TBL] [Abstract][Full Text] [Related]
7. Treatment of invasive pulmonary aspergillosis in neutropenic patients by additional bronchoscopic amphotericin B instillation.
Winkler J; Müller U; Nenoff P; Seyfarth HJ; Vogtmann M; Borte G; Pönisch W; Kahn T; Wirtz H; Schauer J; Hoheisel G
Respiration; 2007; 74(6):663-73. PubMed ID: 17622755
[TBL] [Abstract][Full Text] [Related]
8. Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V; Petraitiene R; Groll AH; Bell A; Callender DP; Sein T; Schaufele RL; McMillian CL; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 1998 Nov; 42(11):2898-905. PubMed ID: 9797223
[TBL] [Abstract][Full Text] [Related]
9. Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy.
Refos JM; Vonk AG; Ten Kate MT; Eadie K; Verbrugh HA; Bakker-Woudenberg IAJM; van de Sande WWJ
PLoS One; 2017; 12(7):e0180961. PubMed ID: 28742113
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
[TBL] [Abstract][Full Text] [Related]
11. Chitinase Induction Prior to Caspofungin Treatment of Experimental Invasive Aspergillosis in Neutropenic Rats Does Not Enhance Survival.
Refos JM; Vonk AG; Ten Kate MT; Verbrugh HA; Bakker-Woudenberg IAJM; van de Sande WWJ
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084744
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice.
Tansho S; Abe S; Ishibashi H; Torii S; Otani H; Ono Y; Yamaguchi H
J Infect Chemother; 2006 Dec; 12(6):355-62. PubMed ID: 17235640
[TBL] [Abstract][Full Text] [Related]
13. High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia.
Lewis RE; Albert NP; Liao G; Wang W; Prince RA; Kontoyiannis DP
J Antimicrob Chemother; 2013 May; 68(5):1148-51. PubMed ID: 23349440
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
[TBL] [Abstract][Full Text] [Related]
15. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
Warn PA; Sharp A; Morrissey G; Denning DW
Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
17. Antifungal Effect of All-
Campione E; Gaziano R; Doldo E; Marino D; Falconi M; Iacovelli F; Tagliaferri D; Pacello L; Bianchi L; Lanna C; Aurisicchio L; Centofanti F; Di Francesco P; Del Principe I; Del Bufalo F; Locatelli F; Pistoia ES; Marra E; Orlandi A
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361288
[No Abstract] [Full Text] [Related]
18. Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
van de Sande WW; Mathot RA; ten Kate MT; van Vianen W; Tavakol M; Rijnders BJ; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2009 May; 53(5):2005-13. PubMed ID: 19237647
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitiene R; Petraitis V; Lyman CA; Groll AH; Mickiene D; Peter J; Bacher J; Roussillon K; Hemmings M; Armstrong D; Avila NA; Walsh TJ
Antimicrob Agents Chemother; 2004 Apr; 48(4):1188-96. PubMed ID: 15047519
[TBL] [Abstract][Full Text] [Related]
20. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
Rijnders BJ; Cornelissen JJ; Slobbe L; Becker MJ; Doorduijn JK; Hop WC; Ruijgrok EJ; Löwenberg B; Vulto A; Lugtenburg PJ; de Marie S
Clin Infect Dis; 2008 May; 46(9):1401-8. PubMed ID: 18419443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
